Cara

CARA NASDAQ
25.58
+0.24
+0.95%
Opening 10:44 07/19 EDT
Open
25.57
Prev Close
25.34
High
25.98
Low
25.35
Volume
181.66K
Avg Vol (3M)
815.84K
52 Week High
27.55
52 Week Low
12.19
% Turnover
0.46%
Market Cap
1.02B
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Cara CARA stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Cara Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing chemical entities designed to alleviate pain and pruritus by focusing on kappa opioid receptors. It is developing a class of product candidates that target the body's peripheral nervous system. The Company operates through the activities related to the discovery and development of therapeutics to treat serious medical conditions, including pain and pruritus. Its product candidate pipeline includes I.V. CR845 for acute pain; I.V. CR845 for uremic pruritus; Oral CR845 for acute and chronic pain, and CR701 for neuropathic and inflammatory pain. I.V. CR845 is an injectable version of peripheral kappa opioid receptor agonist, which is intended for the treatment of acute pain in an acute care setting. CR845 has exhibited anti-pruritic, or anti-itch, potency in standard preclinical models.
MORE >

Recently

Name
Price
%Change